| Previous Close | 3.04 |
| Open | 3.04 |
| Bid | 3.14 x 2200 |
| Ask | 3.15 x 400 |
| Day's Range | 3.04 - 3.16 |
| 52 Week Range | 0.68 - 3.18 |
| Volume | 699,438 |
| Avg. Volume | 935,234 |
| Market Cap | 266.35M |
| Beta | 1.65 |
| PE Ratio (TTM) | -14.79 |
| EPS (TTM) | -0.21 |
| Earnings Date | Aug 7, 2017 - Aug 11, 2017 |
| Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 4.56 |
- Accesswire•14 days ago
Today's Research Reports on Trending Tickers: Nektar Therapeutics and Catalyst Pharmaceuticals Inc.
NEW YORK, NY / ACCESSWIRE / July 12, 2017 / After a dismal 2016, the Biotech Industry has rallied back in 2017 as regulation fears have subsided. The iShares NASDAQ Biotechnology Index ETF and the SPDR ...
- GlobeNewswire•last month
Catalyst Pharmaceuticals Joins Russell 3000 Index
CORAL GABLES, Fla., June 26, 2017-- Catalyst Pharmaceuticals, Inc., a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating neuromuscular ...
- Investopedia•2 months ago
Three Junior Biotechs Ready to Run
Junior biotechs are attracting strong speculative interest that could offer outstanding returns for traders with well-honed risk management skills.
